Blood-brain barrier breached for first time to treat cancer
Advertisement
TORONTO: For the first time, scientists have successfully breached the human blood-brain barrier non-invasively to effectively deliver cancer-fighting drugs into the brain of a patient.
Each person has a protective blood barrier lining the blood vessels in the brain to restrict the passage of large toxic substances from the bloodstream into the brain.
"The blood-brain barrier (BBB) has been a persistent obstacle to delivering valuable therapies to treat disease such as tumours," said Dr Todd Mainprize, principal investigator of the study and Neurosurgeon at Sunnybrook Health Sciences Centre in Canada.
"We are encouraged that we were able to temporarily open this barrier in a patient to deliver chemotherapy directly to the brain tumour," said Mainprize.
The research team infused a chemotherapy drug and tiny, microscopic bubbles, into the bloodstream of the patient who had a malignant brain tumour.
The microbubbles were smaller than red blood cells and pass harmlessly through the circulation.
The researchers then used MRI-guided focused low-intensity ultrasound waves to target blood vessels in the blood-brain barrier (BBB) area near the tumour.
Each person has a protective blood barrier lining the blood vessels in the brain to restrict the passage of large toxic substances from the bloodstream into the brain.
"The blood-brain barrier (BBB) has been a persistent obstacle to delivering valuable therapies to treat disease such as tumours," said Dr Todd Mainprize, principal investigator of the study and Neurosurgeon at Sunnybrook Health Sciences Centre in Canada.
"We are encouraged that we were able to temporarily open this barrier in a patient to deliver chemotherapy directly to the brain tumour," said Mainprize.
The research team infused a chemotherapy drug and tiny, microscopic bubbles, into the bloodstream of the patient who had a malignant brain tumour.
The microbubbles were smaller than red blood cells and pass harmlessly through the circulation.
The researchers then used MRI-guided focused low-intensity ultrasound waves to target blood vessels in the blood-brain barrier (BBB) area near the tumour.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.